Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome

Clinical trial NCT05322096 · COMPLETED

Trial details

NCT number: NCT05322096
Sponsor: Gedeon Richter Plc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prader-Willi Syndrome

Start date: 2022-09-22
Primary completion: 2024-04-10
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.